[Pharmacological study of beta-lactam antibiotics (15). Metabolism of sodium 7 beta-[(2R,3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3- hydroxybutanamido]-7 alpha-methoxy-3- [1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (T-1982)].
D000818:Animals; D001646:Bile / Q000378:metabolism; D002513:Cephamycins / Q000378:metabolism*; D004285:Dogs; D000882:Haplorhini; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D011817:Rabbits; D051381:Rats
D002513:Cephamycins; C035978:cefbuperazone